SAIC Q2: EPS jumps, revenue flat; strong backlog and buybacks but audits, DOJ probe linger

Science Applications International Corporation (NYSE: SAIC) - quick internal read on Q2 FY2026 (quarter ended Aug 1, 2025)

Snapshot - what's happening inside
SAIC remains a government-focused technology integrator. Revenue is roughly flat-to-down year-over-year due to contract completions and ramp dynamics, but profitability and cash generation improved modestly in the quarter. Management is actively deploying capital via dividends and heavy buybacks while using the revolver for working capital swings. Key government audits and a DOJ criminal subpoena remain open risks.

Key facts & figures (as reported)
* Revenues (Q): $1,769M vs $1,818M a year ago (down 3%).
* Revenues (6‑mo): $3,646M vs $3,665M (down 1%).
* Cost of revenues (Q): $1,554M; cost of revenues as % of sales (Q): 87.8%.
* Operating income (Q): $139M (7.9% of revenues) vs $134M a year ago.
* Net income (Q): $127M vs $81M - +57% (benefited from tax items).
* EPS (diluted, Q): $2.71 vs $1.58. Six months diluted EPS: $4.12 vs $3.06.
* Effective tax rate: (17.2)% for the quarter (very low due to $47M IRS audit benefit recognized).
* Adjusted operating income (Q): $182M (10.3% of revenues). Adjusted EBITDA (Q): $185M (10.5% of revenues).
* Backlog: $23,172M total (Funded $3,594M; Negotiated unfunded $19,578M).
* Remaining Performance Obligations (RPO): ~$6.1B (≈79% recognized in 12 months).
* Cash, cash equivalents and restricted cash: $56M (end of period).
* Receivables, net: $951M (down from $1,000M at Jan 31, 2025).
* Operating cash flow (6‑mo): $222M. Free cash dynamics affected by MARPA activity and working capital timing.
* Total debt principal: $2,300M; debt, net of current portion: ~$1,844M. Current portion of debt: $448M.
* Interest expense (Q): ~$31M; six months interest expense: $61M.
* Shares outstanding: ~46.0M (46,022,001 reported); six‑month repurchases ≈2.1M shares for ~$231M. Total repurchased under plan to date: ~26.6M shares for ~$2.3B.
* Quarterly dividend: $0.37 per share (declared and paid); Board declared subsequent $0.37 payable Oct 24, 2025.

Positive takeaways
* Net income and EPS jumped materially this quarter (net income +57% Q/Q) - EPS benefited from a tax settlement and deferment adjustments.
* Adjusted operating income and adjusted EBITDA margins improved year-over-year - underlying contract profitability strengthened in both segments, notably Civilian segment margin expansion.
* Strong backlog ($23.2B) and $6.1B RPO give multi-year revenue visibility; ~79% of RPO expected to convert within 12 months.
* Operating cash flow remains positive ($222M YTD) and management continues capital returns: ongoing dividends and large share repurchases (26.6M shares repurchased to date).
* No goodwill or intangible impairments reported; goodwill of $2,851M intact.

Negative / risk items
* Revenue decline (Q -3%, 6‑mo -1%) from contract completions and ramp‑downs - top-line momentum is weak-to-flat.
* High cost base: cost of revenues ~88% of sales leaves limited operating leverage; operating margin still modest (7.9%).
* Cash on hand is low ($56M) relative to debt and the business scale - SAIC relies on revolver borrowings and receivables sales for liquidity; revolver swings drove current debt classification increases ($448M current debt).
* Total debt remains material (~$2.3B principal) with significant near‑term maturities (principal schedule shows sizeable 2028 and later buckets). Interest expense is meaningful (~$31M Q) and reduces free cash flow.
* Effective tax rate volatility (quarterly negative rate) driven by a one-time IRS audit benefit and accounting for the new tax Act - this makes quarterly comparability noisy.
* Government exposure: ~98% of revenue from U.S. government customers - results vulnerable to appropriations timing, CRs, shutdown risk and changing agency priorities. DCAA indirect cost audits remain open and could lead to adjustments. DOJ subpoenas (antitrust criminal investigation) are unresolved.
* Receivables declined and there are ongoing receivables sales (MARPA) with fees ($7M YTD) - reliance on receivables financing affects cash flow reporting and margin economics.
* Heavy buybacks (and dividends) consume cash and reduced retained earnings - repurchases have materially reduced shares but also reduce liquidity buffers.

What to watch next (near term)
* Q3 revenue and margin trends - can management replace completed work and maintain improved adjusted margins?
* DCAA audit outcomes and DOJ investigation developments - potential reserves or penalties could hit results.
* Debt and liquidity movements - revolver usage, scheduled repayments (current portion dynamics) and any covenant changes.
* Cash conversion vs buybacks/dividends - will capital return pace slow if cash tightens?
* Impact and IRS guidance on the One Big Beautiful Bill Act (R&D expensing) - current estimates are provisional.

Bottom line
SAIC shows improved profitability metrics and strong backlog, but top-line slipped slightly and operating leverage is constrained by a high cost base. The company is returning cash aggressively to shareholders while managing a material debt load and working through government audits and investigations. Investors should weigh improved margins and backlog visibility against debt, liquidity sensitivity, tax-item volatility, and government‑contract concentration risks.